Chapter 5. Phosphodiesterase 4 inhibitors

被引:9
作者
Montana, JG [1 ]
Dyke, HJ [1 ]
机构
[1] Celltech Ltd, Res & Dev, Cambridge CB1 6GS, England
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36 | 2001年 / 36卷
关键词
D O I
10.1016/S0065-7743(01)36045-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:41 / 56
页数:16
相关论文
共 85 条
[1]  
Aebischer E, 1998, HETEROCYCLES, V48, P2225
[2]  
[Anonymous], FIELDS I COMM
[3]  
Aoki M, 2000, J PHARMACOL EXP THER, V295, P1149
[4]   N-arylrolipram derivatives as potent and selective PDE4 inhibitors [J].
Bacher, E ;
Boer, C ;
Bray-French, K ;
Demnitz, FWJ ;
Keller, TH ;
Mazzoni, L ;
Müller, T ;
Walker, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) :3229-3234
[5]  
BAMETTE MS, 1999, PROG DRUG RES, V53, P193
[6]  
Barnard A, 2000, J ROY ANTHROPOL INST, V6, P164
[7]   CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS [J].
BEAVO, JA .
PHYSIOLOGICAL REVIEWS, 1995, 75 (04) :725-748
[8]  
BROWN WM, 1999, CURR OPIN ANTIINFLAM, V1, P39
[9]   7-methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: A potential treatment for asthma [J].
Buckley, G ;
Cooper, N ;
Dyke, HJ ;
Galleway, F ;
Gowers, L ;
Gregory, JC ;
Hannah, DR ;
Haughan, AF ;
Hellewell, PG ;
Kendall, HJ ;
Lowe, C ;
Maxey, R ;
Montana, JG ;
Naylor, R ;
Picken, CL ;
Runcie, KA ;
Sabin, V ;
Tuladhar, BR ;
Warneck, JBH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) :2137-2140
[10]   Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indoles:: Discovery of potent, selective phosphodiesterase type 4 inhibitors [J].
Burnouf, C ;
Auclair, E ;
Avenel, N ;
Bertin, B ;
Bigot, C ;
Calvet, A ;
Chan, K ;
Durand, C ;
Fasquelle, V ;
Féru, F ;
Gilbertsen, R ;
Jacobelli, H ;
Kebsi, A ;
Lallier, E ;
Maignel, J ;
Martin, B ;
Milano, S ;
Ouagued, M ;
Pascal, Y ;
Pruniaux, MP ;
Puaud, J ;
Rocher, MN ;
Terrasse, C ;
Wrigglesworth, R ;
Doherty, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4850-4867